QuidelOrtho Corporation (QDEL) Earnings Per Share (EPS)
QuidelOrtho Corporation (QDEL) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2022-12-31 | $9.66 |
| 2023-12-31 | -$0.15 |
| 2024-12-31 | -$30.54 |
| 2025-12-31 | -$16.69 |
How QDEL compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ATOS | Atossa Therapeutics Inc. | -$4.04 |
| RARE | Ultragenyx Pharmaceutical Inc. | -$5.83 |
| BHVN | Biohaven Ltd. | -$6.86 |
| AGIO | Agios Pharmaceuticals Inc. | -$7.12 |
| NKTR | Nektar Therapeutics | -$9.73 |
These are five companies in the same sector as QDEL with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get QuidelOrtho Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("QDEL")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | QDEL | $13.75 | +11.93% | 2.81M |
| 3 | ||||
| 4 | ||||
| 5 |